D
David A. Hanauer
Researcher at University of Michigan
Publications - 145
Citations - 5471
David A. Hanauer is an academic researcher from University of Michigan. The author has contributed to research in topics: Health care & Medicine. The author has an hindex of 36, co-authored 132 publications receiving 4341 citations. Previous affiliations of David A. Hanauer include New York University & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Tocilizumab for treatment of mechanically ventilated patients with COVID-19.
Emily C. Somers,Gregory A. Eschenauer,Jonathan P. Troost,Jonathan L. Golob,Tejal N Gandhi,Lu Wang,Nina Zhou,Lindsay A Petty,Ji Hoon Baang,Nicholas O Dillman,David Frame,Kevin S. Gregg,Dan R Kaul,Jerod Nagel,Twisha S Patel,Shiwei Zhou,Adam S. Lauring,David A. Hanauer,Emily T. Martin,Pratima Sharma,Christopher Fung,Jason M. Pogue +21 more
TL;DR: In this cohort of mechanically ventilated COVID-19 patients, tocilizumab was associated with lower mortality despite higher superinfection occurrence.
Journal ArticleDOI
Public Awareness, Perception, and Use of Online Physician Rating Sites
TL;DR: Patients are increasingly turning to online physician ratings, just as they have sought ratings for other products and services, and whether these sites influence decisions about selecting a physician is questioned.
Journal ArticleDOI
Supporting information retrieval from electronic health records
TL;DR: The success of EMERSE at the University of Michigan illustrates that free-text EHR search engines can be a valuable tool to help practitioners and researchers retrieve information from EHRs more effectively and efficiently, enabling critical tasks such as patient case synthesis and research data abstraction.
Journal ArticleDOI
Computerized Automated Reminder Diabetes System (CARDS): e-mail and SMS cell phone text messaging reminders to support diabetes management.
TL;DR: Cell phone text messaging to promote BG monitoring is a viable and acceptable option in adolescents and young adults with diabetes, however, maintaining interest levels for prolonged intervals remains a challenge.
Journal ArticleDOI
Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin
Sophie Paczesny,Thomas Braun,John E. Levine,Jason M. Hogan,Jeffrey Crawford,Bryan N. Coffing,Stephen H. Olsen,Sung Won Choi,Hong Wang,Vitor M. Faça,Sharon J. Pitteri,Qing Zhang,Alice Chin,Carrie L. Kitko,Shin Mineishi,Gregory A. Yanik,Edward Peres,David A. Hanauer,Ying Wang,Pavan Reddy,Samir M. Hanash,James L.M. Ferrara +21 more
TL;DR: Elafin has significant diagnostic and prognostic value as a biomarker of skin GVHD and is validated with enzyme-linked immunosorbent assay in samples from 492 patients, showing that elafin concentrations may serve as a noninvasive diagnostic test as well as a prognostic marker in determining GV HD grading in the clinic.